Jonathan P. Foster, Chief Financial Officer of Moleculin Biotech, Inc. (NASDAQ:MBRX), filed a Form 4 on November 6, 2026, reporting transactions dated November 4, 2026, related to the vesting of restricted stock units.

Key Highlights

  • RSU conversion: 41 restricted stock units were converted into 41 shares of common stock on November 4, 2026, on a one-for-one basis.
  • Tax withholding: 10 shares were withheld at $8.46 per share for payment of taxes upon vesting.
  • Resulting ownership: Foster directly held 20,291 shares of common stock following the reported transactions.
  • Remaining RSUs: Foster held 70,854 restricted stock units following the reported transactions.
  • Original grant: The RSUs vesting on November 4, 2026, were part of a grant of 165 restricted stock units made on November 4, 2024, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Foster RSU Vesting and Tax Withholding Details at Moleculin Biotech

According to the Form 4 filed with the SEC, Jonathan P. Foster, serving as Chief Financial Officer of Moleculin Biotech, Inc. (NASDAQ:MBRX), reported two transactions on November 4, 2026. The first was the conversion of 41 restricted stock units into 41 shares of common stock under transaction code M, reflecting a vesting event. The filing notes that restricted stock units convert into common stock on a one-for-one basis, and the price of the derivative security is listed as $0.

The second transaction, coded F, involved the disposition of 10 shares at a price of $8.46 per share. The filing states these shares were "withheld for payment of taxes upon vesting of restricted stock unit awards." After both transactions, Foster directly owned 20,291 shares of common stock. In Table II, the filing reports that Foster's remaining beneficial ownership of restricted stock units stood at 70,854 following the reported transactions.

The filing further explains that on November 4, 2024, Foster was granted 165 restricted stock units, with vesting scheduled in four equal annual installments beginning on the first anniversary of the grant date. The Form 4 was filed by one reporting person and was signed by Jonathan P. Foster on November 6, 2026.

What Was Disclosed

The filing disclosed an RSU vesting event for CFO Jonathan P. Foster on November 4, 2026, covering 41 units converted to common stock, 10 shares withheld for taxes at $8.46, and resulting direct ownership of 20,291 shares and 70,854 remaining RSUs.